DADC
EW icon

D.A. Davidson & Co’s Edwards Lifesciences EW Stock Holding History

D.A. Davidson & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$914K Buy
11,416
+622
+6% +$51.3K 0.01% 958
2025
Q4 		$920K Buy
10,794
+732
+7% +$60.1K 0.01% 920
2025
Q3 		$783K Buy
10,062
+831
+9% +$64.9K 0.01% 957
2025
Q2 		$722K Sell
9,231
-82
-0.9% -$6.12K 0.01% 915
2025
Q1 		$675K Sell
9,313
-720
-7% -$51.5K 0.01% 908
2024
Q4 		$743K Buy
10,033
+300
+3% +$21K 0.01% 874
2024
Q3 		$642K Sell
9,733
-17,356
-64% -$1.26M 0.01% 919
2024
Q2 		$2.5M Hold
27,089
– – 0.02% 476
2024
Q1 		$2.59M Sell
27,089
-1,950
-7% -$164K 0.02% 460
2023
Q4 		$2.21M Sell
29,039
-13,681
-32% -$952K 0.02% 480
2023
Q3 		$2.96M Buy
42,720
+562
+1% +$45.2K 0.03% 374
2023
Q2 		$3.98M Buy
42,158
+344
+0.8% +$29.9K 0.04% 310
2023
Q1 		$3.42M Sell
41,814
-3,001
-7% -$236K 0.04% 336
2022
Q4 		$3.37M Sell
44,815
-5,109
-10% -$394K 0.04% 322
2022
Q3 		$4.18M Sell
49,924
-1,091
-2% -$105K 0.05% 256
2022
Q2 		$4.85M Sell
51,015
-216
-0.4% -$22.4K 0.06% 242
2022
Q1 		$6.03M Buy
51,231
+322
+0.6% +$36.1K 0.07% 233
2021
Q4 		$6.65M Sell
50,909
-1,672
-3% -$195K 0.07% 226
2021
Q3 		$5.95M Sell
52,581
-20
-0% -$2.28K 0.07% 231
2021
Q2 		$5.45M Sell
52,601
-1,375
-3% -$130K 0.06% 242
2021
Q1 		$4.51M Sell
53,976
-5,505
-9% -$465K 0.06% 252
2020
Q4 		$5.34M Buy
59,481
+3,441
+6% +$285K 0.08% 178
2020
Q3 		$4.47M Sell
56,040
-534
-0.9% -$41.7K 0.08% 181
2020
Q2 		$3.91M Buy
56,574
+2,661
+5% +$189K 0.07% 186
2020
Q1 		$3.5M Buy
53,913
+489
+0.9% +$35.3K 0.07% 208
2019
Q4 		$4.14M Buy
53,424
+2,874
+6% +$224K 0.07% 222
2019
Q3 		$3.71M Sell
50,550
-108
-0.2% -$7.59K 0.07% 229
2019
Q2 		$3.12M Sell
50,658
-20,211
-29% -$1.22M 0.06% 249
2019
Q1 		$4.47M Sell
70,869
-1,200
-2% -$68.5K 0.08% 202
2018
Q4 		$3.68M Sell
72,069
-1,347
-2% -$68.2K 0.07% 218
2018
Q3 		$4.26M Sell
73,416
-1,089
-1% -$53.3K 0.08% 215
2018
Q2 		$3.62M Buy
74,505
+1,728
+2% +$80.7K 0.07% 235
2018
Q1 		$3.38M Sell
72,777
-414
-0.6% -$18K 0.07% 230
2017
Q4 		$2.75M Buy
73,191
+5,526
+8% +$203K 0.06% 264
2017
Q3 		$2.46M Sell
67,665
-4,068
-6% -$155K 0.05% 321
2017
Q2 		$2.83M Buy
71,733
+42,789
+148% +$1.56M 0.06% 240
2017
Q1 		$907K Buy
28,944
+18,543
+178% +$581K 0.02% 461
2016
Q4 		$323K Sell
10,401
-7,098
-41% -$230K 0.01% 817
2016
Q3 		$703K Buy
17,499
+16,539
+1,723% +$623K 0.02% 545
2016
Q2 		$31K Buy
960
+300
+45% +$10.3K ﹤0.01% 1590
2016
Q1 		$19K Hold
660
– – ﹤0.01% 1724
2015
Q4 		$17K Hold
660
– – ﹤0.01% 1754
2015
Q3 		$15K Sell
660
-240
-27% -$5.79K ﹤0.01% 1745
2015
Q2 		$21K Buy
+900
New +$20.3K ﹤0.01% 1693
2014
Q4 		– Sell
-1,806
Closed -$30K – 2109
2014
Q3 		$30K Sell
1,806
-2,598
-59% -$41K ﹤0.01% 1571
2014
Q2 		$63K Sell
4,404
-4,848
-52% -$65.7K ﹤0.01% 1330
2014
Q1 		$113K Buy
9,252
+2,418
+35% +$27.9K ﹤0.01% 1073
2013
Q4 		$74K Buy
+6,834
New +$77K ﹤0.01% 1195

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

D.A. Davidson & Co's EW Position: Q1 2026 in Review

D.A. Davidson & Co increased its Edwards Lifesciences (EW) stake by 5.8% in Q1 2026, buying an estimated $51.3K and bringing the position to 11,416 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #958.

D.A. Davidson & Co first reported a position in EW in Q4 2013 and has held it in 48 quarters since. The position peaked at $6.65M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • D.A. Davidson & Co held 11,416 shares of Edwards Lifesciences worth $914K as of Q1 2026.
  • D.A. Davidson & Co bought 622 Edwards Lifesciences shares in Q1 2026, an estimated $51.3K.
  • Edwards Lifesciences made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #958 holding.
  • D.A. Davidson & Co first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 48 quarters since.
  • D.A. Davidson & Co's Edwards Lifesciences position peaked at $6.65M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.